(30mg) weekly IM testosterone with plans for continued monitoring of testosterone and estradiol levels.\nConclusion: Research is needed in monitoring the effects of testosterone therapy on reproductive organs in patients assigned female at birth, and whether anastrozole therapy has protective effects for...
A recentCosmos Study, published by Epic Research on January 16, 2024, revealed that men with low testosterone who are being treated with testosterone replacement therapy (TRT) have an increased risk of cardiovascular disease (CVD) compared to those who are not on TRT. Although bot...
Testosterone is the main male sex hormone and is essential for the maintenance of male secondary sexual characteristics and fertility. Androgen deficiency in young men owing to organic disease of the hypothalamus, pituitary gland or testes has been treat
The findings of a nested case-control study of the National Prostate Cancer Register of Sweden reveal no significant differences in prostate cancer risk among men who previously received testosterone replacement therapy (TRT) compared with that of the general population. However, further analyses ...
Long-Term Exposure to Testosterone Therapy and the Risk of High Grade Prostate Cancer Jacques Baillargeon,* Yong-Fang Kuo, Xiao Fang and Vahakn B. Shahinian From the Departments of Preventive Medicine and Community Health (XF) and Internal Medicine and Sealy Center on Aging, University of Texas ...
INTRODUCTION AND OBJECTIVES Given that some cancers are androgen dependent, there is concern that testosterone replacement therapy will increase a man's risk of developing cancer. To date there are no long term, prospective studies which evaluate the incidence of cancer in men on testosterone ...
Purpose The association between exposure to testosterone replacement therapy (TRT) and prostate cancer risk is controversial. The objective was to examine this association through nationwide, population-based registry data. Methods We performed a nested case-control study in the National Prostate Cancer ...
Type 2 diabetes mellitus (DM), an endocrine disorder, has been implicated in many medical conditions including testosterone deficiency in men, known as hypogonadism, which has been documented for many years. Testosterone therapy in men with DM was testified to improve general health with no ...
The use of metformin and testosterone replacement therapy, either individually or in combination, is associated with significant reductions in the incidence of prostate and colorectal cancer in men across race and ethnic backgrounds, with the reductions most prominent with the combination of the two ...
This cohort study compares COVID-19 hospitalization rates for men with hypogonadism who were not receiving testosterone therapy, men with eugonadism, and